Gastroenterology
Volume 137, Issue 4 , Pages 1261-1269 , October 2009

Multicenter, Randomized, Placebo-Controlled Trial of Amitriptyline in Children With Functional Gastrointestinal Disorders

  • Miguel Saps

      Affiliations

    • Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Children's Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois
    • Corresponding Author InformationReprint requests Address requests for reprints to: Miguel Saps, MD, Division of Gastroenterology, Hepatology, and Nutrition, Children's Memorial Hospital, 2300 Children's Plaza, Box 65, Chicago, Illinois 60614. fax: (773) 880-4036
    • ,
  • Nader Youssef

      Affiliations

    • Center for Pediatric Irritable Bowel & Motility Disorders, Goryeb Children's Hospital at Atlantic Health, Morristown, New Jersey
    • ,
  • Adrian Miranda

      Affiliations

    • Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Medical College of Wisconsin, Milwaukee, Wisconsin
    • ,
  • Samuel Nurko

      Affiliations

    • Center for Motility and Functional Gastrointestinal Disorders, Children's Hospital Boston, Boston, Massachusetts
    • ,
  • Paul Hyman

      Affiliations

    • Division of Pediatric Gastroenterology, Children's Hospital of New Orleans, New Orleans, Louisiana
    • ,
  • Jose Cocjin

      Affiliations

    • Children's Mercy Hospital, Kansas City, Missouri
    • ,
  • Carlo Di Lorenzo

      Affiliations

    • Division of Gastroenterology, Nationwide Children's Hospital, Columbus, Ohio

Received 23 February 2009 ,Accepted 18 June 2009.

References 

  1. Starfield B, Katz H, Gabriel A, et al. Morbidity in childhood—a longitudinal view. N Engl J Med. 1984;310:824–829
  2. Saps M, Seshadri R, Sztainberg M, et al. A prospective school-based study of abdominal pain and other common somatic complaints in children. J Pediatr. 2009;154:322–326
  3. Apley J. The child with abdominal pains. 2nd ed. Oxford: Blackwell Scientific Publications; 1975;
  4. Youssef NN, Murphy TG, Langseder AL, et al. Quality of life for children with functional abdominal pain: a comparison study of patients' and parents' perceptions. Pediatrics. 2006;117:54–59
  5. Stordal K, Nygaard EA, Bentsen BS. Recurrent abdominal pain: a five-year follow-up study. Acta Paediatr. 2005;94:234–236
  6. Kline RM, Kline JJ, Di Palma J, et al. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr. 2001;138:125–128
  7. See MC, Birnbaum AH, Schechter CB, et al. Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment. Dig Dis Sci. 2001;46:985–992
  8. Symon DN, Russell G. Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine. Arch Dis Child. 1995;72:48–50
  9. Huertas-Ceballos A, Macarthur C, Logan S. Pharmacological interventions for recurrent abdominal pain (RAP) in childhood. Cochrane Database Syst Rev 2002;(1):CD003017.
  10. Morgan V, Pickens D, Gautam S, et al. Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut. 2005;54:601–607
  11. Hyams J, Colletti R, Faure C, et al. Functional gastrointestinal disorders: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2002;35(Suppl 2):S110–S117
  12. Veldhuyzen van Zanten SJ, Talley NJ, Bytzer P, et al. Design of treatment trials for functional gastrointestinal disorders. Gut. 1999;45(Suppl 2):II69–II77
  13. Kovacs M. The Children's Depression Inventory. Psychopharmacol Bull. 1985;21:995–998
  14. Spielberger CD. Manual for the Strait-Anxiety Inventory for Children. Palo Alto, CA: Consulting Psychologist Press; 1973;
  15. Walker LS, Smith CA, Garber J, et al. Development and validation of the Pain Response Inventory for Children. Psychol Assess. 1997;9:392–405
  16. Walker LS, Greene JW. The functional disability inventory: measuring a neglected dimension of child health status. J Pediatr Psychol. 1991;16:39–58
  17. Walker LS, Sorrells SC. Brief report: assessment of children's gastrointestinal symptoms for clinical trials. J Pediatr Psychol. 2002;27:303–307
  18. Tesler MD, Savedra MC, Holzemer WL, et al. The word-graphic rating scale as a measure of children's and adolescents' pain intensity. Res Nursing Health. 1991;14:361–371
  19. Camilleri M, Mangel AW, Fehnel SE, et al. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol. 2007;5:534–540
  20. Matsuzawa-Yanagida K, Narita M, Nakajima M, et al. Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites. Neuropsychopharmacology. 2008;33:1952–1965
  21. Silverman DH, Munakata JA, Ennes H, et al. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology. 1997;112:64–72
  22. Naliboff BD, Derbyshire SW, Munakata J, et al. Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med. 2001;63:365–375
  23. Mertz H, Morgan V, Tanner G, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology. 2000;118:842–848
  24. Vase L, Robinson ME, Verne GN, et al. Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain. 2005;115:338–347
  25. Lewis DW, Kellstein D, Dahl G, et al. Children's ibuprofen suspension for the acute treatment of pediatric migraine. Headache. 2002;42:780–786
  26. Patel SM, Stason WB, Legedza A, et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil. 2005;17:332–340
  27. Bridge JA, Birmaher B, Iyengar S, et al. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry. 2009;166:42–49
  28. Fernandes R, Ferreira JJ, Sampaio C. The placebo response in studies of acute migraine. J Pediatr. 2008;152:527–533
  29. Bahar RJ, Collins BS, Steinmetz B, et al. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr. 2008;152:685–689
  30. Drossman DA, Toner BB, Whitehead WE, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology. 2003;125:19–31
  31. Otaka M, Jin M, Odashima M, et al. New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. Aliment Pharmacol Ther. 2005;21(Suppl 2):42–46
  32. Poitras P, Riberdy Poitras M, Plourde V, et al. Evolution of visceral sensitivity in patients with irritable bowel syndrome. Dig Dis Sci. 2002;47:914–920
  33. Talley NJ, Kellow JE, Boyce P, et al. Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial. Dig Dis Sci. 2008;53:108–115

 To view this article's video abstract, go to the AGA's YouTube Channel.

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported in part by the 2003 Clinical Research Award from the American College of Gastroenterology, the CHP 19596 RA501 grant, and grants M01 RR-00048, M01 RR-00084, and M01 RR-02172 from the National Center for Research Resources, National Institutes of Health.

PII: S0016-5085(09)01148-2

doi: 10.1053/j.gastro.2009.06.060

Gastroenterology
Volume 137, Issue 4 , Pages 1261-1269 , October 2009

Article Tools

* Image Usage & Resolution